Details of Disease

Disease Name

Disease Class

DB93: Hepatic fibrosis/cirrhosis

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISDVHK3: Cirrhosis

ICD-11

ICD-11: DB93

Disease Identifiers

MONDO ID

MONDO_0005155

MESH ID

D008103

UMLS CUI

C0023890

MedGen ID

7368

HPO ID

HP:0001394

SNOMED CT ID

19943007

General Information of Disease (ID: DISDVHK3)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
KB174	DMFJBQC	Clinical Trial	NA	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 4 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
PMID27998201-Compound-5	DMVZ0ND	Patented	Small molecular drug	[2]
Quinazoline derivative 10	DMZ3ORT	Patented	Small molecular drug	[3]
Quinazoline derivative 11	DMAH435	Patented	Small molecular drug	[3]
Quinazoline derivative 12	DMVKZU2	Patented	Small molecular drug	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT03855956) Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis. U.S. National Institutes of Health.
2	Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
3	Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.